Satellos Bioscience Inc.

Healthcare · Biotechnology · Canada

Last price 6.815 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 145.77M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Satellos Bioscience Inc., a clinical-stage drug development company, focuses on restoring natural muscle repair and regeneration in degenerative muscle diseases in Canada, the United States, and Australia. The company uses its proprietary discovery platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247, an oral, small molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research ...